Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/1991
05/16/1991CA2072657A1 Method of vaccine or toxoid preparation and immunization by colonization with recombinant microorganisms
05/16/1991CA2071546A1 Anti-viral material
05/16/1991CA2029997A1 Polymyxin conjugates
05/16/1991CA2019425A1 Control of microbial growth with lantibiotic/lysozyme formulations
05/16/1991CA2005122A1 Control of microbial growth with nisin/lysozyme formulations
05/15/1991EP0427633A1 Use of a polypeptide having an interferon gamma activity for the preparation of pharmaceutical compositions useful in the treatment of primitive pleural cancers
05/15/1991EP0427458A2 Use of heptapeptides in the treatment or prophylaxis of muscle wasting
05/15/1991EP0427246A2 Pharmaceutical compositions comprising sulfur containing carboxylic acids as the active agent as well as their use for combatting retroviruses
05/15/1991EP0427189A1 Modified forms of human erythropoietin and DNA sequences encoding genes which can express them
05/15/1991EP0427162A1 Novel insulin derivatives, their preparation and use, and a pharmaceutical composition thereof
05/15/1991EP0426924A1 Production of metal transporter compositions for facilitating the engraftment of histo-incompatible bone marrow and controlling the immune reactions in the recipient host
05/15/1991EP0426913A1 Pharmaceutical composition and method for the suppression of factor VIII inhibitor production
05/15/1991EP0426860A1 New protease inhibitor and production thereof
05/15/1991EP0426857A1 Peptide and adsorbent comprising same immobilized on carrier
05/15/1991EP0426787A1 POLYPEPTIDE RESULTING FROM THE FUSION BETWEEN A MALTOSE-RELATED COMPOUND (MalE) AND A CD4 FRAGMENT FOR NEUTRALIZING THE AIDS VIRUS
05/15/1991EP0357730A4 Blocking, isolating and purifying calcium channels
05/15/1991EP0299963B1 Renin inhibitors having a lactam pseudo dipeptide
05/15/1991CN1051393A Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
05/15/1991CN1051389A Novel antibodies reactive with human carcinomas
05/15/1991CN1051302A Biologically active proteins and method for their prodn.
05/15/1991CN1051299A Methods and compasitions employing certain lysozymes and endoglycosidases
05/15/1991CA2029965A1 Stabilization and maintenance of the nerve growth factor biological activity by use of natural gangliosides or derivatives thereof
05/14/1991WO1991007494A1 Chimeric mouse human antibodies with specificity to hiv antigens
05/14/1991WO1991007493A1 Chimeric mouse human antibodies with specificity to hiv antigens
05/14/1991WO1991007492A1 Monoclonal antibodies
05/14/1991WO1991007434A1 Control of milk secretion
05/14/1991WO1991007431A1 Metal-peptide compositions and methods for stimulating hair growth
05/14/1991WO1991007418A1 Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen
05/14/1991US5015730 Preparation of homogeneous human fibroblast interferon
05/14/1991US5015729 Proteins which are hormone inhibitors for follicle stimulating hormones but not luteinizing hormone, fertility agents for sheep
05/14/1991US5015728 Reaction of endopepsidase and insulin, genetic engineering
05/14/1991US5015641 Antiglaucoma agents
05/14/1991US5015629 Tissue repair
05/14/1991US5015628 Oral diseases, fractionating a digest of casein, alpha-s-casein, beta-casein or salt
05/14/1991US5015627 Stabilized somatotropin for parenteral administration
05/14/1991US5015626 Feeding somatotropin to pigs
05/14/1991US5015583 Process for the purification of plasminogen activators (PA)
05/14/1991CA2068515A1 Control of milk secretion
05/14/1991CA2044627A1 Chimeric mouse human antibodies with specificity to hiv antigens
05/14/1991CA2044609A1 Chimeric mouse human antibodies with specificity to hiv antigens
05/14/1991CA2044590A1 Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen
05/14/1991CA2029766A1 Polypeptide compound and a process for preparation thereof
05/14/1991CA1284250C Viscoelastic collagen solution for ophthalmic use and method of preparation
05/14/1991CA1284248C Pyrrolidone derivatives
05/12/1991WO1991007187A1 Agent for neutralising the procoagulant activity associated with tumor cells
05/12/1991CA2068312A1 Agent for neutralising the procoagulant activity associated with tumor cells
05/11/1991CA2029670A1 Use of a polypeptide with gamma-interferon activity for the preparation of pharmaceutical compositions for the treatment of primitive cancers of the pleura
05/10/1991WO1991007438A1 A method for isolating factor viii
05/08/1991EP0426521A1 Use of interleukine 2 for the treatment of leukemias
05/08/1991EP0426488A1 Production of modified superoxide dismutase
05/08/1991EP0426467A1 Prodrugs of 6-mercaptopurine and 6-thioguanine
05/08/1991EP0426463A2 Method of encapsulating biologically active substances, a capsule produced by the method, its use, and a fodder containing such capsules
05/08/1991EP0426458A2 Human monocyte growth factor
05/08/1991EP0426066A2 Ace inhibitors for use for preventing onset of type II diabetes
05/08/1991EP0425956A2 ACE inhibitors for use for stabilizing or causing regression of atherosclerosis in coronary arteries
05/08/1991EP0425909A2 Method for rehabilitating the vasorelaxant action of the coronary arteries impaired through atherosclerosis or hypercholesterolemia employing an ace inhibitor
05/08/1991EP0425892A2 Process for enhancing the bioavailability of drugs with peptide bonds
05/08/1991EP0425828A2 Facteur thymique sérique for prevention and remedy of disorders of decrease in the number of blood corpuscles
05/08/1991EP0425821A1 The use of human ADF (=Adult T-cell leukemia-derived factor) for producing a medicament
05/08/1991EP0425661A1 A new method for tapping the immunological repertoire
05/08/1991EP0425580A1 Synthetic hiv protease gene and method for its expression
05/08/1991EP0425536A1 Nonglycosylated human interleukin-3 compositions
05/08/1991EP0425507A1 Compositions and methods for treating skin conditions and promoting wound healing.
05/08/1991EP0425482A1 Human insulin analogs and preparations containing them.
05/08/1991DE3936777A1 Quervernetzte tumor-nekrose-faktoren Cross-linked tumor necrosis factors
05/08/1991DE3935738A1 Arzneimittel, enthaltend das humane parathormon-fragment (1-37) als aktiven wirkstoff A drug containing the human parathyroid hormone-fragment (1-37) as the active drug
05/08/1991CN1051199A Modified biological material
05/08/1991CN1051182A Polypeptides useful as blockers of calcium channels
05/08/1991CA2029457A1 Modified forms of human erythropoietin and dna sequences encoding genes which can express them
05/07/1991WO1991006563A1 Reduced irreversible bombesin antagonists
05/07/1991US5013845 Condensation reaction, inhibitors of angiotensin converting enzyme
05/07/1991US5013824 Human interleukin-4 peptides and conjugates thereof
05/07/1991US5013723 New thymopentin retro-inverso analogs and fragments thereof, a process of preparation of the new compounds and the intermediates obtained therein
05/07/1991US5013722 Oligopeptides as appetite suppressants
05/07/1991US5013721 Anorexigenic and hypotensive peptides
05/07/1991US5013720 SAP-6-Val proteins and methods
05/07/1991US5013719 Administering cyclosporin A and alpha-difluoromethylornithine
05/07/1991US5013718 Method for treating iron overload using EPO
05/07/1991US5013714 Buffered balanced salt solution, hydroxypropyl methyl cellulose, chondroitin sulfate and Epidermal Growth Factor; ocular wound healing
05/07/1991US5013713 Prolonged release of biologically active somatotropin
05/07/1991US5013661 Lipopolysaccharide-specific acyloxyacyl hydrolase
05/07/1991US5013649 Proteins; bone disorders
05/07/1991US5013556 Lipids derivatized with polyoxyethylene glycol, drug delivery, antitumor agents
05/07/1991US5013552 Modified pollen grains for delivering biologically active substances to plants and animals
05/07/1991US5013550 Antibiotics called "chloropolysporins B and C", a process for their preparation, and their therapeutic and veterinary use
05/07/1991US5013546 Decreaseing immunoglobulin production by administering a dipeptide or tripeptide of tyrosine and glycine
05/07/1991US5013542 Applying polypeptide derived from proline rich protein contained in saliva
05/07/1991CA2045494A1 Reduced irreversible bombesin antagonists
05/07/1991CA2029289A1 Insulin derivatives, process for their preparation, their use and a pharmaceutical preparation containing them
05/07/1991CA2027601A1 Antitumor antibiotic bu-3983t
05/04/1991CA2331088A1 Urinary tumor associated antigen, antigenic subunits uses and methods of detection
05/04/1991CA2029268A1 Peptides aiding nerve regeneration
05/03/1991WO1991006322A1 Magnetocontrollable carrier with physiologically active substance and method for making said carrier
05/03/1991CA2045504A1 Magnetically controlled carrier with physiologically active agent and process for preparing thereof
05/03/1991CA2029216A1 Process of producing modified superoxide dismutase
05/03/1991CA2002209A1 Pharmaceutical composition and method for the suppression of factor viii inhibitor production
05/02/1991WO1991006009A1 N-acetylmuramidase m1
05/02/1991WO1991005867A1 Erythropoietin isoforms
05/02/1991WO1991005855A1 Modified biological material
05/02/1991WO1991005853A1 Growth hormone antagonists
1 ... 3009 3010 3011 3012 3013 3014 3015 3016 3017 3018 3019 3020 3021 3022 3023 3024 3025 3026 3027 3028 3029 ... 3163